These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 26071831)

  • 1. Rivaroxaban for cancer-associated cardiac thrombosis.
    Di Nisio M; Carella C; Natoli C; Porreca E; De Tursi M
    Am J Med; 2015 Oct; 128(10):e43-4. PubMed ID: 26071831
    [No Abstract]   [Full Text] [Related]  

  • 2. Intra-ventricular thrombus resolution after anticoagulation therapy with rivaroxaban in patient with poor anticoagulation quality.
    Esteve-Pastor MA; Orenes-Piñero E; Roldán V; Lacunza-Ruiz J; Valdés M; Marín F
    Cardiol J; 2018; 25(1):151-154. PubMed ID: 29512103
    [No Abstract]   [Full Text] [Related]  

  • 3. Rivaroxaban for thromboprophylaxis in a patient receiving electroconvulsive therapy.
    Shuman M; Hieber R; Moss L; Patel D
    J ECT; 2015 Mar; 31(1):e19-20. PubMed ID: 25587812
    [No Abstract]   [Full Text] [Related]  

  • 4. Rivaroxaban for Left Ventricular Thrombus.
    Yassin AS; Abubakar H; Mishra T; Adam O; Hartman M; Pahuja M; Shokr M
    Am J Ther; 2019; 26(4):e511-e515. PubMed ID: 29420319
    [No Abstract]   [Full Text] [Related]  

  • 5. Rivaroxaban Used for Treatment of a Left Ventricular Thrombus in a Patient With Nonischemic Cardiomyopathy.
    Abubakar H; Yassin AS; Shokr M
    Am J Ther; 2018; 25(6):e706-e709. PubMed ID: 29324466
    [No Abstract]   [Full Text] [Related]  

  • 6. Superior mesenteric artery thrombosis after abrupt discontinuation of rivaroxaban.
    Adams CB; Acquisto NM; Rotoli JM; LoStracco T; Shamaskin AR; Pasternack JS
    Am J Emerg Med; 2016 Apr; 34(4):764.e5-7. PubMed ID: 26439093
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rivaroxaban for the treatment of cerebral venous thrombosis.
    Mutgi SA; Grose NA; Behrouz R
    Int J Stroke; 2015 Oct; 10 Suppl A100():167-8. PubMed ID: 26502976
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of rivaroxaban in left ventricular thrombi.
    Abdelnaby M; Almaghraby A; Abdelkarim O; Saleh Y; Hammad B; Badran H
    Anatol J Cardiol; 2019 Jan; 21(1):47-50. PubMed ID: 30587707
    [No Abstract]   [Full Text] [Related]  

  • 9. Outcomes in patients with nontriple antiphospholipid syndrome (APS) anticoagulated with rivaroxaban.
    Htut TW; Milne D; Khan MM; Watson HG
    Int J Lab Hematol; 2021 Oct; 43(5):e252-e253. PubMed ID: 33470532
    [No Abstract]   [Full Text] [Related]  

  • 10. Recurrent deep vein thrombosis with rivaroxaban in a patient with metastatic testicular cancer.
    Eid TJ; Kalkat B; Shah SA
    J Pharm Pract; 2015 Jun; 28(3):233. PubMed ID: 25979903
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanical Prosthetic Heart Valve Thrombosis in a Patient Receiving Rivaroxaban.
    Carvalho Silva DM; Braga A; de Jesus I; Neves J
    Cardiology; 2019; 143(3-4):116-120. PubMed ID: 31473736
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large protruding thrombus over left atrial appendage occlusion device successfully treated with apixaban.
    Freixa X; Scalone G; Martín-Yuste V; Vidal B
    Eur Heart J; 2015 Jun; 36(23):1427. PubMed ID: 25834098
    [No Abstract]   [Full Text] [Related]  

  • 13. Resolution of Extensive Coronary Thrombosis under Rivaroxaban Treatment.
    Yuksel M; Yildiz A; Tapan U; Ertas F; Alan S
    Arq Bras Cardiol; 2015 Dec; 105(6):642-6. PubMed ID: 26761372
    [No Abstract]   [Full Text] [Related]  

  • 14. Effective management of heparin-resistant thrombosis: a case study on rivaroxaban therapy guided by thromboelastography.
    Hou C; Zhai B; Yang B; Zhang L; Li Y; Lu X
    Ann Hematol; 2024 Aug; 103(8):3267-3268. PubMed ID: 38822845
    [No Abstract]   [Full Text] [Related]  

  • 15. The factor Xa inhibitor rivaroxaban reduces cardiac dysfunction in a mouse model of myocardial infarction.
    Bode MF; Auriemma AC; Grover SP; Hisada Y; Rennie A; Bode WD; Vora R; Subramaniam S; Cooley B; Andrade-Gordon P; Antoniak S; Mackman N
    Thromb Res; 2018 Jul; 167():128-134. PubMed ID: 29843086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rivaroxaban use in patients with antiphospholipid syndrome and previous venous thromboembolism.
    Sciascia S; Breen K; Hunt BJ
    Blood Coagul Fibrinolysis; 2015 Jun; 26(4):476-7. PubMed ID: 25923780
    [No Abstract]   [Full Text] [Related]  

  • 17. Case reports of diagnostic error: liposarcoma mistaken for hematoma in an obese female with concurrent ipsilateral thrombosis on rivaroxaban.
    Lake JCW; Tsui E; Wu J; Baker M; Kieffer K
    Diagnosis (Berl); 2019 Aug; 6(3):301-305. PubMed ID: 30511930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis Comparing the Effect of Rivaroxaban Versus Vitamin K Antagonists for Treatment of Left Ventricular Thrombi.
    Saleh Y; Al-Abcha A; Abdelkarim O; Elwany M; Abdelfattah OM; Abdelnabi M; Almaghraby A
    Am J Cardiol; 2021 Dec; 161():123-125. PubMed ID: 34656296
    [No Abstract]   [Full Text] [Related]  

  • 19. Rivaroxaban inhibits oxidative and inflammatory reactions in advanced glycation end product-exposed tubular cells by blocking thrombin/protease-activated receptor-2 system.
    Ishibashi Y; Matsui T; Fukami K; Ueda S; Okuda S; Yamagishi S
    Thromb Res; 2015 Apr; 135(4):770-3. PubMed ID: 25636461
    [No Abstract]   [Full Text] [Related]  

  • 20. [Good efficacy and safety profile in clinical practice].
    MMW Fortschr Med; 2015 Nov; 157(20):66-7. PubMed ID: 26977521
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.